Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01374256|
Recruitment Status : Unknown
Verified June 2011 by Taipei Veterans General Hospital, Taiwan.
Recruitment status was: Not yet recruiting
First Posted : June 15, 2011
Last Update Posted : June 15, 2011
Infections caused by imipenem-resistant Acinetobacter baumannii are associated with high mortality and morbidity. The treatment choices for this resistant pathogen are limited.
The objective of the present proposal is to evaluate the effectiveness of combination therapy of imipenem and sulbactam in patients contracted with A. baumannii, and to correlate the clinical effect with the in vitro synergistic results.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Observational Model:||Case Control|
|Official Title:||Effectiveness of Imipenem and Sulbactam in the Treatment of Bacteremic Patients Contracted With Imipenem-resistant Acinetobacter Baumannii|
|Study Start Date :||July 2011|
|Estimated Primary Completion Date :||July 2013|
|Estimated Study Completion Date :||July 2013|
Patients with Acinetobacter baumannii bacteremia treated with combination therapy of imipenem and sulbactam
Not combination therapy
Patients with Acinetobacter baumannii bacteremia not treated with combination therapy of imipenem and sulbactam
- survival rate [ Time Frame: 14 days ]
- survival rate [ Time Frame: 28 days ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01374256
|Contact: Te-Li Chen, PhD||886228712121 ext email@example.com|
|Contact: Shu-Chen Kuo||886228712121 ext firstname.lastname@example.org|
|Taipei Veterans General Hospital, Taiwan||Not yet recruiting|
|Taipei, Taiwan, 112|
|Principal Investigator: Te-li Chen, PhD|
|Principal Investigator:||Te-Li Chen, PhD||Taipei Veterans General Hospital, Taiwan|